Patent Assignment
Reel/Frame 049705/0637
Assignment of Assignor's Interest
Recorded: 2019-07-09
Pages: 8
Assignors
JONES, PHILIP
Executed: 2019-03-04
CROSS, JASON
Executed: 2019-03-04
BURKE, JASON
Executed: 2019-02-13
MCAFOOS, TIMOTHY
Executed: 2019-03-04
KANG, ZHIJUN
Executed: 2019-03-04
Assignee
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
210 WEST 7TH ST., AUSTIN, TEXAS, 78701
Covered Property
(1)
Substituted Heterocyclic Inhibitors of PTPN11
Patent:
10,954,243 →
Application:
16/401,047 →
Publication:
US 2019/0389867
PCT:
PCT/US2019/030277 ↗
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 9, 2019
From: JONES, PHILIP; CROSS, JASON; BURKE, JASON; MCAFOOS, TIMOTHY
To: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 049705/0617 →
Assignment of Assignor's Interest
Oct 2, 2019
From: JONES, PHILIP; CROSS, JASON; BURKE, JASON; MCAFOOS, TIMOTHY
To: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 050608/0913 →
Assignment of Assignor's Interest
Oct 21, 2020
From: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
To: NAVIRE PHARMA, INC.
Reel/Frame 054130/0519 →
Security Interest
Jan 17, 2024
From: CALCILYTIX THERAPEUTICS INC.; ADRENAS THERAPEUTICS INC.; PHOENIX TISSUE REPAIR, INC.; NAVIRE PHARMA, INC.
To: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 066342/0154 →
Security Interest
Jan 19, 2024
From: BRIDGEBIO PHARMA, INC.; QED THERAPEUTICS, INC.; EIDOS THERAPEUTICS, INC.; THERAS, INC.
To: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 066355/0126 →
Release of Security Interest in Patent Collateral
Mar 5, 2025
From: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
To: BRIDGEBIO PHARMA, INC.; QED THERAPEUTICS, INC.; EIDOS THERAPEUTICS, INC.; ML BIO SOLUTIONS INC.
Reel/Frame 070551/0095 →